Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma
Open Access
- 4 November 2024
- journal article
- case report
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-7
Abstract
Fumarate hydratase (FH) mutated papillary renal cell carcinoma is an aggressive variant of kidney cancer that poorly responds to conventional targeted therapies and immunotherapy. Here, we present the 10-year follow-up of a heavily pre-treated patient with several lines of therapy, achieving a remarkable complete response to anti-PD-1 rechallenge. In addition, we highlight a common immune-related adverse event of anti-PD-1, eosinophilia, as a possible biomarker of response and using TCGA data analysis, provide proof-of-concept for tumor expression of the eosinophil-related gene SIGLEC8, as a promising powerful predictor of prognosis for papillary renal cell carcinoma patients.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (11/05331-0, 12/23478-0, 14/10290-9)
This publication has 51 references indexed in Scilit:
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2024
- Papillary Renal Cell Carcinoma: A Review of Prospective Clinical TrialsCurrent Treatment Options in Oncology, 2023
- IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancerCancer Cell, 2022
- Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case reportFamilial Cancer, 2020
- Targeting tumor-associated acidity in cancer immunotherapyCancer Immunology, Immunotherapy, 2018
- Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodiesEuropean Journal of Cancer, 2017
- Metabolic Instruction of ImmunityCell, 2017
- Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian familyFamilial Cancer, 2016
- Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient CancerCancer Cell, 2014
- Dendritic cell?tumor cell hybrid vaccination for metastatic cancerCancer Immunology, Immunotherapy, 2004